AMTI(Delisted)
Applied MolecularยทNASDAQ
--
--(--)
AMTI Profile
Applied Molecular Transport Inc.
A clinical-stage biopharmaceutical company that develops novel oral biologic therapies to treat severe autoimmune, metabolic inflammatory diseases
450 East Jamie Court, South San Francisco, CA 94080
--
Applied Molecular Transport Inc., originally incorporated in Delaware in September 2010, is a limited liability company. The Company is a clinical-stage biopharmaceutical company that leverages its proprietary technology platform to design and develop new candidate oral biologic products for the treatment of autoimmune, inflammatory, metabolic and other diseases. Their proprietary technology platform allows them to leverage existing natural cell trafficking pathways to facilitate active transport of therapeutic payloads through the IE barrier. Active transport is an efficient mechanism that utilizes the cell's own machinery to transport material across the IE barrier.
